 |
0 Diseases |  |
2 Trials |
|
2 Trials |  |
1 News |  |
- | heparin sodium (VR496) / Vectura, lexgenleucel-T (VRX496) / VIRxSYS Corp
Trial completion: Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV (clinicaltrials.gov) - Oct 26, 2019
P1/2, N=25, Completed, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed